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Abstract
Background: Delay in diagnosis and treatment of pulmonary tuberculosis (PTB) leads to severe disease, adverse
outcomes and increased transmission. Assessing the extent of delay and its effect on disease progression in TB
affected settings has clinical and programmatic importance. Hence, the aim of this study was to investigate the
possible effect of delay on infectiousness (cavitation and smear positivity) of patients at diagnosis in Somali
pastoralist area, Ethiopia.
Methods: A cross-sectional study was conducted between December 2017 and October 2018, and 434 newly
coming and confirmed PTB patients aged ≥15 years were recruited in five facilities. Data were collected using
interview, record-review, anthropometry, Acid-fast bacilli and chest radiography techniques. Log-binomial regression
models were used to reveal the association of delay and other factors associated with cavitation and smear positivity,
and ROC Curve was used to determine discriminative ability and threshold delays.
Results: Median age of patients was 30 years. Of all, 62.9% were males, and 46.5% were pastoralists. Median diagnosis
delay was 49 days (IQR = 33–70). Cavitation was significantly associated with diagnosis delay [P < 0.001]; 22.2% among
patients diagnosed within 30 days of illness and 51.7% if delay was over 30 days. The threshold delay that optimizes
cavitation was 43 days [AUC (95% CI) = 0.67(0.62–0.72)]. Smear positivity was significantly increased in patients delayed
over 49 days [p = 0.02]. Other factors associated with cavitation were age≤ 35 years [APR (95% CI) =1.3(1.01–1.6)],
chronic diseases [APR (95% CI) = 1.8(1.2–2.6)] and low MUAC*female [APR (95% CI) = 1.8(1.2–2.8)]. Smear positivity was
also associated with age≤ 35 years [APR (95% CI) =1.4(1.1–1.8)], low BMI [APR (95% CI) =1.3(1.01–1.7)] and low MUAC
[APR (95% CI) =1.5(1.2–1.9)].
Conclusion: This study highlights delay in diagnosis of pulmonary TB remained high and increased infectiousness of
patients in pastoral settings of Ethiopia. Hence, delay should be targeted to improve patient outcomes and reduce
transmission in such settings.
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Background
Tuberculosis (TB) remains the leading killer of infec-
tious diseases. Globally, it caused an estimated 10
million cases and 1.3 million deaths in 2017. Ethiopia
ranked 11th among the 22 high TB burden countries
and 4th in Africa with around 172, 000 new cases in
2017 [1]. The disease is more prevalent in pastoral
communities of the country [2]. The End-TB strategy
sets early diagnosis and prompt treatment of cases as
pillars to ending the global epidemics by 2030 [3].
Particularly in Ethiopia, the national TB control pro-
gram (NTP) primarily focuses on detection of pre-
sumptive TB cases who present themselves to health
facilities, aka passive case finding strategy [4].
However, this passive approach struggles to achieve
the required case detection rates in resource-limited
settings, leaving millions of potentially infectious cases
undiagnosed in communities [5, 6]. Nearly one-third of
TB cases in Ethiopia were not detected in 2017 [1]. The
number of undetected cases could be equal or more
than the number of cases detected by the healthcare
system in certain communities of the country [6, 7]. In
Somali Regional State of Ethiopia (SRS), TB case detec-
tion rates have never exceeded 50% in the past years [8].
The problem is likely influenced by healthcare seeking
behavior of patients or health system deficiencies [9, 10].
Patients may delay without seeking healthcare, or the
healthcare providers may fail to identify presented
cases [11].
Delay in diagnosis and treatment leads to severe dis-
ease, death, and facilitates transmission in households
and congregate settings. Fail to timely treat PTB leaves
destructive damages to lung tissues, the classical hall-
mark is pulmonary cavitation [12, 13]. The cavities
formed are caves for Mycobacterium tuberculosis
(MTB) and release higher bacilli load in aerosols [14],
which is the channel of transmission. Cavities also slow
smear conversion (prolongs contagious period), cause
adverse treatment outcomes, and leave permanent lung
damages even after successful treatment [15]. Along
with disease progression, delay also extends contagious
period and contact time between patients and suscep-
tible contacts [16].
This highlights assessment of delay in medical care
and its impact is very helpful to evaluate the effective-
ness of TB programs in controlling the disease and its
transmission in affected communities. There is also lim-
ited data on the prevalence of cavitary TB and the toler-
able delays from clinical and programmatic perspectives
in Ethiopia. Hence, the aim of this study was to evaluate
the possible effect of diagnosis delay on pulmonary cavi-
tation and smear positivity as proxy measures of patient
infectiousness in Somali Regional State of Ethiopia, a
pastoralist predominated area.
Methods
Study setting
Four hospitals (Kharamara, Dege-habour, Kebri-Daher
and Gode) and one health center (Abilelie) were in-
cluded based on their high patient flow, presence of
radiologic facility, and geographic location in Somali
Regional State of Ethiopia. Approximately 85% of the
region’s population are rural and lead pastoral life that is
characterized by seasonal migration following climatic
conditions [17]. The health facilities provide TB diagno-
sis services as per the national guideline, which involves
two spot-spot smear microscopy spaced by 30 min (and
morning on demand), chest radiography, GeneXpert,
pathology and clinical investigations [4].
Study design and population
A facility-based cross-sectional study was conducted
between December 2017 and October 2018. Newly diag-
nosed PTB patients aged ≥15 years were included re-
gardless of smear status and treatment category. Patients
aged ≥15 years manifest similar pathological features and
the same diagnosis approaches are followed [4]. People
in this age category acquire competent immunity that is
key in cavity formation [18], cover 80% of all TB cases,
and account for almost 100% of transmissions [19].
Patients with other pulmonary co-morbidities (bronchitis,
pneumonia and lung cyst) were excluded.
Sample size and sampling technique
The minimum sample size estimated was 282 using
OpenEpi303 software for cross-sectional studies. The
assumptions were 95% CI, 80% power, 1:1 ratio of non-
delayed/delayed, 27.5% of non-delayed and 45% of de-
layed patients had cavitation in related study [12], 5%
precision and 10% non-response rate, given delay above
30 days as critical point at which risk of transmission in-
creases [20]. We included all the available samples in the
analysis to increase the power of the test, which raised
the final sample size to 434. Newly upcoming PTB pa-
tients during the study period were recruited immedi-
ately after diagnosis and before treatment initiation.
Data collection
A mix of methods was used to collect data including
face-to-face interview, record review, anthropometry,
Acid-Fast Bacilli (AFB) and chest radiography. Inter-
views were conducted using a structured questionnaire
(translated into native Somali and Amharic languages),
questions were adapted from multinational study in
Eastern Mediterranean WHO region [21] and related
studies in Ethiopia [11, 22, 23]. Records were reviewed
to substantiate co-morbidities and medical history. An-
thropometry measurements were also taken. Upon com-
pletion of interviews and anthropometry, patients were
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linked to laboratory and radiology units using request
forms prepared for this purpose. Nurses working in
DOTS clinics carried out recruitment, interview, record
review and anthropometry procedures. Training was
provided on sampling and data collection procedures by
the principal investigator and a local research assistant.
AFB examination
Three sputum specimens from each patient were col-
lected; morning sputum at home, and two spot speci-
mens spaced by 30min after the patient delivered the
morning specimen. A pair of smears was prepared from
each specimen, air dried and heat fixed. One slide of
each pair was examined at hospital laboratories using
Ziehl Neelsen (ZN) staining technique. The rest three
smears were transported and examined blindly at
Armauer Hansen Research Institute (AHRI) TB labora-
tory in Addis Ababa, Ethiopia (Fig. 1). The results were
interpreted as negative (no AFB), scanty (1–9 AFB/100
field), 1+ (10–99 AFB/100 field), 2+ (1–10 AFB/field),
3 + (> 10 AFB/field) [4].
Chest radiography
All patients were set for Chest X-ray examinations to
identify lung cavitation, measure cavity size and count the
number of cavities. A senior radiologist at Kharamara
hospital examined all the X-ray films and digital images.
The radiologist was blinded to radiologic and AFB results
reported during the standard initial diagnosis. Sample of
X-ray films (n = 41) were randomly picked and blindly re-
checked by another radiologist to ensure the reliability of
X-ray readings. As of rechecking, we found levels of 95.1%
[84.6–100%] kappa agreement for cavity identification,
0.84 [0.64, 0.93] Cohen’s kappa coefficient for cavity size,
and 85.7% [63.7–96.9%] Cohen’s proportion of zero differ-
ence for cavity count.
Measurements
Pulmonary cavitation
Is presence of an air-containing lucent space within a
consolidation or a mass or nodule surrounded by infil-
trate or fibrotic wall identified upon radiological examin-
ation [18, 24]
Smear positivity
Was confirmed if at least one sputum smear was positive
for AFB upon rechecking at hospital and TB research
laboratories [4]
Diagnosis delay
Is the time duration from onset of pulmonary symptoms
to date of diagnosis. Patients were asked the first dates
of illness onset, healthcare provider consultation, and
diagnosis. If patients were unsure of the dates, they were
assisted to associate with main religious or cultural
events. Patient cards were also cross-checked. Then the
interval between illness onset and diagnosis was calcu-
lated. Cough was the benchmark of illness onset, but
another symptom that compelled the patients to seek
care was also used in the absence of cough.
Mid-upper arm circumference (MUAC)
Was measured using inelastic paper tapes and catego-
rized at 23 cm cutoff (low if MUAC ≤23) according to
FANTA’s recommended cutoff to assess undernutrition
in adults [25]
Fig. 1 AFB examination algorithm at hospital and research laboratories
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Body mass index (BMI)
Was computed from weight (kilograms) and height
(meter-square) measures, and categorized at 18.5 Kg/M2
cutoff (low if BMI < 18.5) according to FANTA’s recom-
mended Cutoff to assess undernutrition in Adults [25].
Data processing and analysis
Data were double entered and validated using EpiData
version 3.1; and analyzed using Stata version 14 (Stata-
Corp, College Station, Texas 77,845 USA). Descriptive
statistics was done to summarize delays in diagnosis,
cavitation, smear positivity and explanatory variables.
Since cavitation and smear positivity were common out-
comes (> 10%), prevalence ratios with 95% confidence
intervals (CI) were used to reveal the association of delay
and other factors associated with cavitation and smear
positivity. Two log-binomial regression models were
fitted using cavitation and smear positivity as separate
outcomes of interest. Significance was determined at p ≤
0.05, and variables with p ≤ 0.2 in bivariate analyses were
included in final multivariable models. Receiver Operat-
ing Characteristic (ROC) curve was used to determine
the discriminative ability of delay to predict patients with
cavitation and smear positivity. Threshold delays were
determined at given sensitivity (> 70%) and maximum
positive likelihood ratio.
Results
Patient characteristics
Totally, 434 pulmonary TB patients were included; all
and 421 of them had complete chest radiography and
AFB results, respectively. The median age of participants
was 30 years, ranged 15 to 82 years. The majority
(62.9%1) was male, and close to half (46.5%) were reliant
on pastoralism (of which, 36% nomadic). Regarding clin-
ical characteristics, majorities were new cases (90.3%),
and 2.3% were co-infected with HIV (Table 1).
The median diagnosis delay from onset of illness to
the date of TB diagnosis was 49 days (IQR = 33–70),
ranged 8 to 362 days. Four patients had diagnosis delay
greater than 254 days.
Patient infectiousness (cavitation and smear positivity)
Of the 434 PTB cases, 45.6% [95%CI: 40.9–50.4%] had
single-to-five cavities (mean, 1.8 ± 0.9 cavities) with
mean diameter of 2.8 ± 1.0 cm. Of the non-cavitary cases,
5.5% had consolidated lesions but not duly branded as
cavity. Whereas, 42.0% [95%CI: 37.3–46.9%] of patients
were smear positive upon rechecking. In hospital labora-
tories, 19.2% of smear positive patients were misidenti-
fied as smear negative and 2.9% of smear negative as
smear positive. Smear positivity was multifold among
cavitary patients (75.3%) compared with non-cavitary
counterparts (13.7%), [P < 0.001]. Conversely, cavitation
was 82.5% [95%CI: 76.1–87.8%] among smear positive
patients. AFB examination correctly identified 75.3%
[95%CI: 68.6 81.2%] of patients with cavitation (sensi-
tivity) and 86.3% [95%CI: 81.2–90.5%] without cavitation
(specificity) (Table 2).
Delay and other factors associated with patient
infectiousness
Cavitation was significantly associated with diagnosis
delay [p < 0.001]. When categorized at 25th, 50th and
75th percentiles, cavitation was continually increased
among patients with diagnosis delay of 31–49 days [APR
(95%CI) =1.8 (1.2–2.8)], 50–70 days [APR (95%CI) =2.4
(1.6–3.7)] and 71+ days [APR (95%CI) = 2.7 (1.8–4.1)],
given diagnosis delay ≤30 days as reference. Ninety per-
cent (90%) of cavitary patients had delay above 30 days
(Table 3). Smear positivity was also significantly in-
creased among patients with diagnosis delay above 49
days [APR (95%CI) = 1.3 (1.1–1.6), p = 0.02] (Table 4).
Other factors associated with cavitation were age ≤ 35
years [APR (95%CI) = 1.3(1.01–1.6)], chronic diseases
(Hypertension/chronic Heart/Renal Disease) [APR
(95%CI) =1.8 (1.2–2.6)], and low MUAC (in female only)
[APR (95%CI) =1.8 (1.2–2.8)] (Table 3). Similarly, smear
positivity was associated with age ≤ 35 years [APR
(95%CI) =1.4 (1.1–1.8)], low BMI [APR (95%CI) =1.3
(1.01–1.7)], and low MUAC [APR (95%CI) =1.5(1.2–
1.9)] (Table 4).
Discriminative ability of delay to predict cavitation and
smear positivity
The ROC curve shows that diagnosis delay discriminated
pulmonary cavitation, and the area under the ROC curve
(AUC) was 0.67 [95%CI: 0.62–0.72]. The threshold delay
was determined at 43 days, at which the resulting sensi-
tivity, specificity and the likelihood ratio for positive test
result were 74.6, 52.1% and 1.6, respectively (Fig. 2). At
this cutoff point, delay can correctly classify 62.4% of pa-
tients with or without cavitation, and 60.0% of patients
delayed longer than 43 days without obtaining diagnosis.
Nonetheless, diagnosis delay revealed poor discrimina-
tive ability to predict smear positivity [AUC (95%CI):
0.56 (0.51–0.62)] (Fig. 3).
Discussion
The present finding reveals that close to half (45.6%) of
all and 82.5% of smear positive patients with pulmonary
TB had one or more cavities; 42% were smear positive,
and half of patients delayed more than 7 weeks (49 days)
and few nearly a year without medical care. Cavitation
was increased in patients who delayed longer than 30
days and optimized at threshold delay of 43 days. Simi-
larly, smear positivity was increased in patients who de-
layed above 7 weeks.
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Cavitation and smear positivity were reciprocally il-
lustrative, and about half of patients had intricate
form of the disease and were capable of transmitting
TB. The cavitation rate matches with the maximum
assumption of 50% rate that happens if patients do
not receive treatment during the entire course of the
disease [26, 27]. It surpassed 34.0% [28] and 21% [29]
findings reported elsewhere. Cavitation among smear
positive patients was almost twice to previous reports
of 49.9% [29] and 38.3% [30] in other places. None-
theless, smear positivity was comparable to other re-
ports in Ethiopia [31–33]. This implies that many
Table 1 Socio-demographic and clinical characteristics of TB
patients in Somali region, Ethiopia, December 2017 to October 2018
Characteristics of patients (N = 434) Frequency (%)
Sex
Male 273 (62.9)
Female 161 (37.1)
Age group
15 to 23 115 (26.5)
24 to 30 112 (25.8)
31 to 50 123 (28.3)
51+ 84 (19.4)
Literacy level
Illiterate 267 (61.5)
Primary 45 (10.4)
Secondary 64 (14.7)
Tertiary 58 (13.4)
Marital status
Single 131(30.2)
Married 265 (61.1)
Divorced/separated/widowed 38 (8.7)
Residence
Rural 215 (49.5)
Urban 215 (49.5)
Refugee/displaced 4 (1.0)
Livelihood
Pastoralism 202 (46.5)
Other 232 (53.5)
Income
Saving 54(12.5)
Income = expense 303 (69.8)
Indebt 77 (17.7)
Cough
Yes 412 (94.9)
No 22 (5.1)
Haemoptysis
Yes 33 (7.6)
No 401 (92.4)
Chest pain
Yes 250 (57.6)
No 184 (42.4)
Breathing difficulty
Yes 93 (21.4)
No 341 (78.6)
Functional status
Good 60 (13.8)
Ambulatory 360 (83.0)
Table 2 Smear positivity versus cavitation results matrix
Cavitary TB Total
Yes (%) No (%)
AFB result
Positive 146 (75.3) 31 (13.7) 177 (42.0)
Negative 48 (24.7) 196 (86.3) 244 (58.0)
Total 194 227 421
Key: The percentages indicate the proportions of smear positive and negative
patients among Cavitary and non-Cavitary cases
Table 1 Socio-demographic and clinical characteristics of TB
patients in Somali region, Ethiopia, December 2017 to October 2018
(Continued)
Characteristics of patients (N = 434) Frequency (%)
Bedridden 14 (3.2)
Treatment category
New 392 (90.3)
Retreatment 42 (9.7)
History of tuberculosis
Yes 65 (15.0)
No 369 (85.0)
HIV status
Positive 10 (2.3)
Negative 422 (97.2)
Unknown 2 (0.5)
Diabetes mellitus
Yes 16 (3.7)
No 412 (94.9)
Unknown 6 (1.4)
Smoking history
Ever smoker 45 (10.4)
Never smokers 389 (89.6)
Khat chewing
Ever chewer 58 (13.4)
Never chewer 376 (86.6)
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patients in the study area received medical care after
the disease gets severe and hazardous.
Our study reveals that the elevated levels of cavita-
tion and smear positivity were attributed to delays in
diagnosis and treatment. The threshold delay (43 days)
that optimizes cavitation was below the median delay
(49 days), or 60% of patients had diagnosis delay lon-
ger than the threshold delay. Extreme delay does not
only increase infectiousness as figured out here or
elsewhere [12, 13], but it also prolongs the contagious
period and contact time between patients and con-
tacts [16]. The majority of infectious patients (90% of
cavitary and 84% of smear positive) delayed longer
than a month with average six-plus household mem-
bers. Household transmission could be, therefore,
higher in pastoral communities bearing in mind their
Table 3 Factors Associated with Pulmonary cavitation of TB patients in Somali region, Ethiopia, December 2017 to October 2018
Characteristics (n = 434) Total PTB cases n (%) Cavitary TB n (%) P-value PR (95% CI) P-value APR (95% CI)
Sex
Female 161 (37.1) 70 (43.5) 0.49* 1 – –
Male 273 (62.9) 128 (46.9) 1.1 (0.9, 1.3)
Age
15 to 35 251 (57.8) 125 (49.8) 0.04 1.3 (1.01, 1.6) 0.04 1.3 (1.01, 1.6)
36+ 183 (42.2) 73 (39.9) 1 1
Livelihood
Pastoralism 202 (46.5) 96 (47.5) 0.45* 1.1 (0.9, 1.3) – –
Non-pastoralism 232 (53.5) 102 (44.0) 1
Smoking
Ever smoker 45 (10.4) 23 (51.1) 0.40* 1.1 (0.8, 1.5) – –
Never smoker 389 (89.6) 175 (45.0) 1
BCG scar
Yes 52 (12.0) 26 (50.0) 0.48* 1.1 (0.8, 1.5) – –
No 382 (88.0) 172 (45.0) 1
Chronic diseases (HTP/CHD/CRD)
Yes 20 (4.6) 12 (60) 0.13 1.3 (0.9, 1.9) 0.006 1.8 (1.2, 2.6)
No 414 (95.4) 186 (44.9) 1 1
MUAC female (n = 161)
Low (≤23 cm) 93 (57.8) 51 (54.8) 0.002 2.0 (1.3, 3.0) 0.01 1.8 (1.13, 2.8)
High (> 23 cm) 68 (42.2) 19 (27.9) 1 1
MUAC male (n = 273)
Low (≤23 cm) 154 (56.4) 74 (48.1) 0.63* 1.1 (0.8, 1.4) – –
High (> 23 cm) 119 (43.6) 54 (45.4) 1
BMI
Low (< 18.5) 304 (70.0) 149 (49.0) 0.04 1.3 (1.01, 1.7) 0.23 1.2 (0.9, 1.5)
High (≥18.5) 130 (30.0) 49 (37.7) 1 1
Prior history of TB
Yes 65 (15.0) 31 (47.7) 0.71* 1.1 (0.8, 1.4) – –
No 369 (85.0) 167 (45.3) 1
Delay in diagnosis (days)
30 or less 90 (20.7) 20 (22.2) 1 1 – 1
31 to 49 138 (31.8) 58 (42.0) 0.004 1.9 (1.2, 2.9) 0.006 1.8 (1.2, 2.8)
50 to 70 98 (22.6) 54 (55.1) < 0.001 2.5 (1.6, 3.8) < 0.001 2.4 (1.6, 3.7)
71 or more 108 (24.9) 66 (61.1) < 0.001 2.8 (1.8, 4.2) < 0.001 2.7 (1.8, 4.1)
Key: MUAC and BMI Cutoffs were 23 cm and 18.5 Kg/M2; Delay categorized at 25th, 50th and 75th quartile days;1 indicates reference category; *indicates the
variable not included in multivariable regression analysis; BCG Bacillus Calmette-Guerin, PR Prevalence ratio, APR Adjusted prevalence ratio, HTP/CHD/CRD
Hypertension/Chronic Heart Disease/Chronic Renal Disease
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petite transitory huts with closed indoor spaces.
Moreover, the high delays could threaten treatment
outcomes. The high cavitation due to delay could re-
sult in treatment failure/relapse, emergence of drug
resistance and permanent lung impairments [28]. Re-
cent findings call for extended treatment of cavitary
TB with a combination of new drugs and strategies
[34], yet no special strategy is currently in place in
Ethiopia. Hence, the effects of delay on treatment
outcomes and household transmission should be eval-
uated in such areas.
In addition to delay, cavitation and smear positivity
were also associated with younger (≤35 years), under-
nutrition and the presence of chronic diseases co-
morbidity after adjusting for potential confounders. The
risk of cavitation is likely higher in younger and immune
competent patients [35, 36]. This is because concomitant
and weakening physical conditions blunt inflammatory
responses in older people [37]. The association of cavita-
tion and smear positivity with undernutrition could be
either way; undernutrition led to immune-deficiency and
enhanced disease progression [38, 39], or the disease itself
Table 4 Factors Associated with Sputum Smear positivity of TB patients in Somali region, Ethiopia, December 2017 to October 2018
Characteristics (n = 434) Total PTB cases n (%) Smear positive TB n (%) P-value PR (95% CI) P-value APR (95% CI)
Sex
Female 157 (37.3) 58 (36.9) 0.11 1 0.17 1
Male 264 (62.7) 119 (45.1) 1.2 (0.9, 1.5) 1.2 (0.9, 1.5)
Age
15 to 35 245 (58.2) 119 (48.6) 0.002 1.5 (1.2, 1.9) 0.007 1.4 (1.1, 1.8)
36+ 176 (41.8) 58 (33.0) 1 1
Livelihood
Pastoralism 194 (46.1) 81 (41.8) 0.91* 0.98 (0.79, 1.24) – –
Non-pastoralism 227 (53.9) 96 (42.3) 1
Smoking
Ever smoker 43 (10.2) 22 (51.2) 0.17 1.2 (0.9, 1.7) 0.28 1.2 (0.8, 1.6)
Never smoker 378 (89.8) 155 (41.0) 1 1
BCG scar
Yes 52 (12.4) 23 (44.2) 0.61* 1.01 (0.7, 1.4) – –
No 369 (87.6) 154 (41.7) 1
Chronic diseases (HTP/CHD/CRD)
Yes 20 (4.8) 8 (40.0) 0.85* 0.95 (0.5, 1.6) – –
No 401 (95.2) 169 (42.1) 1
MUAC
Low (≤23 cm) 235 (55.8) 119 (50.6) < 0.001 1.6 (1.3, 2.1) 0.003 1.5 (1.2, 1.9)
High (> 23 cm) 186 (44.2) 58 (31.2) 1 1
BMI
Low (< 18.5) 294 (69.8) 135 (45.9) 0.02 1.4 (1.1, 1.8) 0.04 1.3 (1.01, 1.7)
High (≥18.5) 127 (30.2) 42 (33.1) 1 1
Prior history of TB
Yes 65 (15.4) 22 (33.8) 0.17 0.8 (0.5, 1.1) 0.25 0.8 (0.6, 1.2)
No 356 (84.6) 155 (43.5) 1 1
Delay in diagnosis (days)
49 or less 222 (52.7) 83 (37.4) 0.04 1 0.02 1
50 or more 199 (47.3) 94 (47.2) 1.3 (1.01, 1.6) 1.3 (1.1, 1.6)
Key: MUAC and BMI Cutoffs were 23 cm and 18.5 Kg/M2; Delay categorized at median day;1 indicates reference category; *indicates the variable not included in
multivariable regression analysis; BCG Bacillus Calmette-Guerin, AFB Acid-Fast Bacilli, PR Prevalence ratio, APR Adjusted prevalence ratio, HTP/CHD/CRD
Hypertension/Chronic Heart Disease/Chronic Renal Disease
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led to under-nutrition [40]. Unlike this study, other stud-
ies revealed diabetes, smoking and low income [41–43] as
factors associated with cavitation and smear positivity.
The reason why these were not witnessed in the current
study might be due to the small number of cases that
cohabit these factors.
However, this study is subjected to certain limitation.
The reduced sensitivity of Chest X-ray, and salivary spu-
tum and missed smears might underestimate cavitation,
and smear positivity, respectively. Recall bias might in-
fluence the precision of delay. Moreover, the proportion
of pastoralists seems less represented due to the reduced
Fig. 2 ROC curve (horizontal = l-specificity, vertical = sensitivity) illustrating diagnosis delay as predictor of pulmonary cavitation
Fig. 3 ROC curve (horizontal = l-specificity, vertical = sensitivity) illustrating diagnosis delay as predictor of smear positivity
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case notification that was observed during dry seasons
when they move for pasture and water.
Conclusion
This study highlights delay in diagnosis and treatment
remained high and substantially increased infectiousness
of patients with pulmonary tuberculosis in pastoral set-
tings in Ethiopia. Delay of 43 days looks the threshold
delay at which risk of cavitation increases significantly,
but around two-third of patients obtained diagnosis after
this cutoff point. The high levels of cavitation and smear
positivity because of excessive delays suggests a threat of
high disease transmission and adverse treatment out-
comes in the pastoral area. Thus, delay in diagnosis and
treatment of TB cases should be targeted for effective
control of the disease and prevent the risk of transmis-
sion in the pastoralist areas of the country. Strategies
that suit socio-cultural needs of pastoralists such as mo-
bile screening services need to be adapted to ensure
early detection and treatment of TB.
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